Company Search:
Advanced Search
Sponsored Links
VANC Pharmaceuticals Inc Company Snapshot
VANC Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares VANC Pharmaceuticals Inc with three other pharmaceutical manufacturers in North America: Karyopharm Therapeutics Inc of the United States (2015 sales of $250,000.00 ), Aurinia Pharmaceuticals Inc (302,710.55 Canadian Dollars [US$227,090.43 ] of which 100% was Therapeutic Drug), and Lixte Biotechnology Holdings, Incorporation which is based in the United States ($200,000.00 ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
VANC Pharmaceuticals Inc
  Stock Performance Chart for VANC Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): .20
(Figures in Canadian Dollars)
1 Week -9.1%   13 Weeks 33.3%  
4 Weeks -31.0%   52 Weeks -50.6%  
VANC Pharmaceuticals Inc Key Data:
  Ticker: NPH Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 301,508
(Year Ending Jan 2016).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 13,201,150
  Fiscal Yr Ends: December Shares Outstanding: 60,005,225
  Share Type: Common Closely Held Shares: 1,412,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.